Sam Brodovsky

Sam Brodovsky is a Senior Associate at Ally Bridge Group in New York, where he focuses on their private equity strategy with a specialization in investments in medical technology. In this role, he is responsible for sourcing, evaluating, and managing investments in the medtech sector, leveraging his extensive analytical experience and strategic insight into healthcare innovation.

Prior to joining Ally Bridge Group in 2024, Sam was a Medical Device Equity Research Analyst at Truist Securities, where he covered the medical supplies and devices sector, providing in-depth research and investment recommendations on public companies in this space. His background also includes earlier roles in institutional asset management at PNC and equity research at BTIG, further enriching his expertise in healthcare and finance.

Sam holds a Bachelor of Business Administration in Finance from Temple University’s Fox School of Business. His career has been rooted in healthcare investments and research, establishing him as a specialist in medical technology, medical devices, and the broader life sciences sector.